Patient Guide: Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 227 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05502237
Status: 🟢 Enrolling Now
Condition: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung
Phase: PHASE3

Where You Can Participate

This study is available at 227 locations across the country.

Top locations include:
  • • Glendale, Arizona
  • • San Marcos, California
  • • Santa Barbara, California
  • • And 224 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer - Join Clinical Trial NCTNCT05502237

How to Join This Clinical Trial - NCTNCT05502237

Learn how to participate in this PHASE3 trial studying an investigational therapy for Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Lung Neoplasms, Carcinoma, Non-Small-Cell Lung
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05502237 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 227 locations. Find a study site near you:

Clinical Research Site

Glendale, Arizona 85304 - United States

Status: WITHDRAWN

Clinical Research Site

San Marcos, California 92069 - United States

Status: WITHDRAWN

Clinical Research Site

Santa Barbara, California 93105 - United States

Status: WITHDRAWN

Clinical Research Site

Whittier, California 90606 - United States

Status: RECRUITING

Clinical Research Site

Norwich, Connecticut 06360 - United States

Status: WITHDRAWN

Clinical Research Site

Washington, District of Columbia 20052 - United States

Status: RECRUITING

Clinical Research Site

Lake City, Florida 32024 - United States

Status: WITHDRAWN

Clinical Research Site

Sarasota, Florida 34232 - United States

Status: WITHDRAWN

Clinical Research Site

Tampa, Florida 33612 - United States

Status: RECRUITING

Clinical Research Site

Atlanta, Georgia 30318 - United States

Status: WITHDRAWN

And 217 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Lung Neoplasms, Carcinoma, Non-Small-Cell Lung:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships